company_name,company_ticker,company_lei,company_cik,year,quarter,start_date,end_date,filing_date,parent,tag,financial_name,factor,balance,unit,value
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2011.0,Q2,,2011-06-30,2011-08-09 15:19:09+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,503744.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2011.0,Q2,,2011-06-30,2011-08-09 15:19:09+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,861399.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2011.0,Q2,,2011-06-30,2011-08-09 15:19:09+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,1365143.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2011.0,Q2,,2011-06-30,2011-08-09 15:19:09+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,6761.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2011.0,Q2,,2011-06-30,2011-08-09 15:19:09+00:00,totalnoncurrentassets,noncurrentnotereceivables,Noncurrent Note & Lease Receivables,+,debit,usd,1378473.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2011.0,Q2,,2011-06-30,2011-08-09 15:19:09+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,14025.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2011.0,Q2,,2011-06-30,2011-08-09 15:19:09+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,1392498.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2011.0,Q2,,2011-06-30,2011-08-09 15:19:09+00:00,,totalassets,Total Assets,=,debit,usd,2764402.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2011.0,Q2,,2011-06-30,2011-08-09 15:19:09+00:00,totalcurrentliabilities,shorttermdebt,Short-Term Debt,+,credit,usd,0.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2011.0,Q2,,2011-06-30,2011-08-09 15:19:09+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,2627657.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2011.0,Q2,,2011-06-30,2011-08-09 15:19:09+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,2193099.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2011.0,Q2,,2011-06-30,2011-08-09 15:19:09+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,4820756.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2011.0,Q2,,2011-06-30,2011-08-09 15:19:09+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,7958506.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2011.0,Q2,,2011-06-30,2011-08-09 15:19:09+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,7958506.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2011.0,Q2,,2011-06-30,2011-08-09 15:19:09+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,12779262.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2011.0,Q2,,2011-06-30,2011-08-09 15:19:09+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,53385911.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2011.0,Q2,,2011-06-30,2011-08-09 15:19:09+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-63400771.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2011.0,Q2,,2011-06-30,2011-08-09 15:19:09+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,-10014860.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2011.0,Q2,,2011-06-30,2011-08-09 15:19:09+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,-10014860.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2011.0,Q2,,2011-06-30,2011-08-09 15:19:09+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,-10014860.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2011.0,Q2,,2011-06-30,2011-08-09 15:19:09+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,2764402.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2011.0,Q3,,2011-09-30,2011-11-09 17:01:22+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,67370.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2011.0,Q3,,2011-09-30,2011-11-09 17:01:22+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,588407.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2011.0,Q3,,2011-09-30,2011-11-09 17:01:22+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,655777.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2011.0,Q3,,2011-09-30,2011-11-09 17:01:22+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,6267.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2011.0,Q3,,2011-09-30,2011-11-09 17:01:22+00:00,totalnoncurrentassets,noncurrentnotereceivables,Noncurrent Note & Lease Receivables,+,debit,usd,1427181.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2011.0,Q3,,2011-09-30,2011-11-09 17:01:22+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,14025.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2011.0,Q3,,2011-09-30,2011-11-09 17:01:22+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,1441206.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2011.0,Q3,,2011-09-30,2011-11-09 17:01:22+00:00,,totalassets,Total Assets,=,debit,usd,2103250.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2011.0,Q3,,2011-09-30,2011-11-09 17:01:22+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,4469879.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2011.0,Q3,,2011-09-30,2011-11-09 17:01:22+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,2330856.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2011.0,Q3,,2011-09-30,2011-11-09 17:01:22+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,6800735.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2011.0,Q3,,2011-09-30,2011-11-09 17:01:22+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,3860838.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2011.0,Q3,,2011-09-30,2011-11-09 17:01:22+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,3860838.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2011.0,Q3,,2011-09-30,2011-11-09 17:01:22+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,10661573.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2011.0,Q3,,2011-09-30,2011-11-09 17:01:22+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,55425299.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2011.0,Q3,,2011-09-30,2011-11-09 17:01:22+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-63983622.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2011.0,Q3,,2011-09-30,2011-11-09 17:01:22+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,-8558323.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2011.0,Q3,,2011-09-30,2011-11-09 17:01:22+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,-8558323.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2011.0,Q3,,2011-09-30,2011-11-09 17:01:22+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,-8558323.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2011.0,Q3,,2011-09-30,2011-11-09 17:01:22+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,2103250.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2012.0,Q1,,2012-03-31,2012-05-10 14:15:56+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,6123340.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2012.0,Q1,,2012-03-31,2012-05-10 14:15:56+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,1617526.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2012.0,Q1,,2012-03-31,2012-05-10 14:15:56+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,7740866.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2012.0,Q1,,2012-03-31,2012-05-10 14:15:56+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,5279.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2012.0,Q1,,2012-03-31,2012-05-10 14:15:56+00:00,totalnoncurrentassets,noncurrentnotereceivables,Noncurrent Note & Lease Receivables,+,debit,usd,1819658.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2012.0,Q1,,2012-03-31,2012-05-10 14:15:56+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,14025.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2012.0,Q1,,2012-03-31,2012-05-10 14:15:56+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,1833683.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2012.0,Q1,,2012-03-31,2012-05-10 14:15:56+00:00,,totalassets,Total Assets,=,debit,usd,9579828.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2012.0,Q1,,2012-03-31,2012-05-10 14:15:56+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,2084471.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2012.0,Q1,,2012-03-31,2012-05-10 14:15:56+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,965336.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2012.0,Q1,,2012-03-31,2012-05-10 14:15:56+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,3049807.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2012.0,Q1,,2012-03-31,2012-05-10 14:15:56+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,3317168.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2012.0,Q1,,2012-03-31,2012-05-10 14:15:56+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,3317168.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2012.0,Q1,,2012-03-31,2012-05-10 14:15:56+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,6366975.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2012.0,Q1,,2012-03-31,2012-05-10 14:15:56+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2012.0,Q1,,2012-03-31,2012-05-10 14:15:56+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,79844515.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2012.0,Q1,,2012-03-31,2012-05-10 14:15:56+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-76631662.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2012.0,Q1,,2012-03-31,2012-05-10 14:15:56+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,3212853.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2012.0,Q1,,2012-03-31,2012-05-10 14:15:56+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,3212853.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2012.0,Q1,,2012-03-31,2012-05-10 14:15:56+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,3212853.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2012.0,Q1,,2012-03-31,2012-05-10 14:15:56+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,9579828.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2012.0,Q2,,2012-06-30,2012-08-09 14:36:38+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,27426900.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2012.0,Q2,,2012-06-30,2012-08-09 14:36:38+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,16149789.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2012.0,Q2,,2012-06-30,2012-08-09 14:36:38+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,1408719.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2012.0,Q2,,2012-06-30,2012-08-09 14:36:38+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,44985408.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2012.0,Q2,,2012-06-30,2012-08-09 14:36:38+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,2464.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2012.0,Q2,,2012-06-30,2012-08-09 14:36:38+00:00,totalnoncurrentassets,longterminvestments,Long-Term Investments,+,debit,usd,4010787.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2012.0,Q2,,2012-06-30,2012-08-09 14:36:38+00:00,totalnoncurrentassets,noncurrentnotereceivables,Noncurrent Note & Lease Receivables,+,debit,usd,1936609.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2012.0,Q2,,2012-06-30,2012-08-09 14:36:38+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,19511.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2012.0,Q2,,2012-06-30,2012-08-09 14:36:38+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,5966907.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2012.0,Q2,,2012-06-30,2012-08-09 14:36:38+00:00,,totalassets,Total Assets,=,debit,usd,50954779.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2012.0,Q2,,2012-06-30,2012-08-09 14:36:38+00:00,totalcurrentliabilities,shorttermdebt,Short-Term Debt,+,credit,usd,0.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2012.0,Q2,,2012-06-30,2012-08-09 14:36:38+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,1154469.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2012.0,Q2,,2012-06-30,2012-08-09 14:36:38+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,3765094.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2012.0,Q2,,2012-06-30,2012-08-09 14:36:38+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,4919563.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2012.0,Q2,,2012-06-30,2012-08-09 14:36:38+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,4803717.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2012.0,Q2,,2012-06-30,2012-08-09 14:36:38+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,4803717.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2012.0,Q2,,2012-06-30,2012-08-09 14:36:38+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,9723280.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2012.0,Q2,,2012-06-30,2012-08-09 14:36:38+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2012.0,Q2,,2012-06-30,2012-08-09 14:36:38+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,128421609.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2012.0,Q2,,2012-06-30,2012-08-09 14:36:38+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-87190110.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2012.0,Q2,,2012-06-30,2012-08-09 14:36:38+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,41231499.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2012.0,Q2,,2012-06-30,2012-08-09 14:36:38+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,41231499.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2012.0,Q2,,2012-06-30,2012-08-09 14:36:38+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,41231499.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2012.0,Q2,,2012-06-30,2012-08-09 14:36:38+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,50954779.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2012.0,Q3,,2012-09-30,2012-11-13 16:13:06+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,17244049.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2012.0,Q3,,2012-09-30,2012-11-13 16:13:06+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,20123315.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2012.0,Q3,,2012-09-30,2012-11-13 16:13:06+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,1285246.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2012.0,Q3,,2012-09-30,2012-11-13 16:13:06+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,38652610.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2012.0,Q3,,2012-09-30,2012-11-13 16:13:06+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,1970.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2012.0,Q3,,2012-09-30,2012-11-13 16:13:06+00:00,totalnoncurrentassets,longterminvestments,Long-Term Investments,+,debit,usd,0.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2012.0,Q3,,2012-09-30,2012-11-13 16:13:06+00:00,totalnoncurrentassets,noncurrentnotereceivables,Noncurrent Note & Lease Receivables,+,debit,usd,2655594.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2012.0,Q3,,2012-09-30,2012-11-13 16:13:06+00:00,totalnoncurrentassets,intangibleassets,Intangible Assets,+,debit,usd,0.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2012.0,Q3,,2012-09-30,2012-11-13 16:13:06+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,19511.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2012.0,Q3,,2012-09-30,2012-11-13 16:13:06+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,2675105.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2012.0,Q3,,2012-09-30,2012-11-13 16:13:06+00:00,,totalassets,Total Assets,=,debit,usd,41329685.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2012.0,Q3,,2012-09-30,2012-11-13 16:13:06+00:00,totalcurrentliabilities,shorttermdebt,Short-Term Debt,+,credit,usd,0.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2012.0,Q3,,2012-09-30,2012-11-13 16:13:06+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,2505520.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2012.0,Q3,,2012-09-30,2012-11-13 16:13:06+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,2469675.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2012.0,Q3,,2012-09-30,2012-11-13 16:13:06+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,4975195.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2012.0,Q3,,2012-09-30,2012-11-13 16:13:06+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,4663395.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2012.0,Q3,,2012-09-30,2012-11-13 16:13:06+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,4663395.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2012.0,Q3,,2012-09-30,2012-11-13 16:13:06+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,9638590.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2012.0,Q3,,2012-09-30,2012-11-13 16:13:06+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2012.0,Q3,,2012-09-30,2012-11-13 16:13:06+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,128766492.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2012.0,Q3,,2012-09-30,2012-11-13 16:13:06+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-97075397.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2012.0,Q3,,2012-09-30,2012-11-13 16:13:06+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,31691095.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2012.0,Q3,,2012-09-30,2012-11-13 16:13:06+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,31691095.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2012.0,Q3,,2012-09-30,2012-11-13 16:13:06+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,31691095.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2012.0,Q3,,2012-09-30,2012-11-13 16:13:06+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,41329685.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2013.0,Q1,,2013-03-31,2013-05-09 16:16:55+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,9067000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2013.0,Q1,,2013-03-31,2013-05-09 16:16:55+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,12049000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2013.0,Q1,,2013-03-31,2013-05-09 16:16:55+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,1573000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2013.0,Q1,,2013-03-31,2013-05-09 16:16:55+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,22689000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2013.0,Q1,,2013-03-31,2013-05-09 16:16:55+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,108000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2013.0,Q1,,2013-03-31,2013-05-09 16:16:55+00:00,totalnoncurrentassets,longterminvestments,Long-Term Investments,+,debit,usd,0.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2013.0,Q1,,2013-03-31,2013-05-09 16:16:55+00:00,totalnoncurrentassets,noncurrentnotereceivables,Noncurrent Note & Lease Receivables,+,debit,usd,0.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2013.0,Q1,,2013-03-31,2013-05-09 16:16:55+00:00,totalnoncurrentassets,intangibleassets,Intangible Assets,+,debit,usd,0.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2013.0,Q1,,2013-03-31,2013-05-09 16:16:55+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,93000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2013.0,Q1,,2013-03-31,2013-05-09 16:16:55+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,93000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2013.0,Q1,,2013-03-31,2013-05-09 16:16:55+00:00,,totalassets,Total Assets,=,debit,usd,22890000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2013.0,Q1,,2013-03-31,2013-05-09 16:16:55+00:00,totalcurrentliabilities,shorttermdebt,Short-Term Debt,+,credit,usd,0.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2013.0,Q1,,2013-03-31,2013-05-09 16:16:55+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,5978000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2013.0,Q1,,2013-03-31,2013-05-09 16:16:55+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,3312000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2013.0,Q1,,2013-03-31,2013-05-09 16:16:55+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,9290000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2013.0,Q1,,2013-03-31,2013-05-09 16:16:55+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,6351000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2013.0,Q1,,2013-03-31,2013-05-09 16:16:55+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,6351000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2013.0,Q1,,2013-03-31,2013-05-09 16:16:55+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,15641000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2013.0,Q1,,2013-03-31,2013-05-09 16:16:55+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2013.0,Q1,,2013-03-31,2013-05-09 16:16:55+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,134999000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2013.0,Q1,,2013-03-31,2013-05-09 16:16:55+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-127750000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2013.0,Q1,,2013-03-31,2013-05-09 16:16:55+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,7249000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2013.0,Q1,,2013-03-31,2013-05-09 16:16:55+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,7249000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2013.0,Q1,,2013-03-31,2013-05-09 16:16:55+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,7249000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2013.0,Q1,,2013-03-31,2013-05-09 16:16:55+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,22890000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2013.0,Q2,,2013-06-30,2013-08-09 07:02:23+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,8312000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2013.0,Q2,,2013-06-30,2013-08-09 07:02:23+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,83988000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2013.0,Q2,,2013-06-30,2013-08-09 07:02:23+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,2349000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2013.0,Q2,,2013-06-30,2013-08-09 07:02:23+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,94649000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2013.0,Q2,,2013-06-30,2013-08-09 07:02:23+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,489000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2013.0,Q2,,2013-06-30,2013-08-09 07:02:23+00:00,totalnoncurrentassets,longterminvestments,Long-Term Investments,+,debit,usd,0.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2013.0,Q2,,2013-06-30,2013-08-09 07:02:23+00:00,totalnoncurrentassets,noncurrentnotereceivables,Noncurrent Note & Lease Receivables,+,debit,usd,0.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2013.0,Q2,,2013-06-30,2013-08-09 07:02:23+00:00,totalnoncurrentassets,intangibleassets,Intangible Assets,+,debit,usd,0.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2013.0,Q2,,2013-06-30,2013-08-09 07:02:23+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,94000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2013.0,Q2,,2013-06-30,2013-08-09 07:02:23+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,94000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2013.0,Q2,,2013-06-30,2013-08-09 07:02:23+00:00,,totalassets,Total Assets,=,debit,usd,95232000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2013.0,Q2,,2013-06-30,2013-08-09 07:02:23+00:00,totalcurrentliabilities,shorttermdebt,Short-Term Debt,+,credit,usd,0.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2013.0,Q2,,2013-06-30,2013-08-09 07:02:23+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,4980000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2013.0,Q2,,2013-06-30,2013-08-09 07:02:23+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,2989000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2013.0,Q2,,2013-06-30,2013-08-09 07:02:23+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,7969000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2013.0,Q2,,2013-06-30,2013-08-09 07:02:23+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,973000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2013.0,Q2,,2013-06-30,2013-08-09 07:02:23+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,973000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2013.0,Q2,,2013-06-30,2013-08-09 07:02:23+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,8942000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2013.0,Q2,,2013-06-30,2013-08-09 07:02:23+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2013.0,Q2,,2013-06-30,2013-08-09 07:02:23+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,224079000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2013.0,Q2,,2013-06-30,2013-08-09 07:02:23+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-137789000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2013.0,Q2,,2013-06-30,2013-08-09 07:02:23+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,86290000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2013.0,Q2,,2013-06-30,2013-08-09 07:02:23+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,86290000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2013.0,Q2,,2013-06-30,2013-08-09 07:02:23+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,86290000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2013.0,Q2,,2013-06-30,2013-08-09 07:02:23+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,95232000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2013.0,Q3,,2013-09-30,2013-11-12 16:46:25+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,12064000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2013.0,Q3,,2013-09-30,2013-11-12 16:46:25+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,70041000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2013.0,Q3,,2013-09-30,2013-11-12 16:46:25+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,5244000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2013.0,Q3,,2013-09-30,2013-11-12 16:46:25+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,87349000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2013.0,Q3,,2013-09-30,2013-11-12 16:46:25+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,617000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2013.0,Q3,,2013-09-30,2013-11-12 16:46:25+00:00,totalnoncurrentassets,longterminvestments,Long-Term Investments,+,debit,usd,0.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2013.0,Q3,,2013-09-30,2013-11-12 16:46:25+00:00,totalnoncurrentassets,noncurrentnotereceivables,Noncurrent Note & Lease Receivables,+,debit,usd,0.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2013.0,Q3,,2013-09-30,2013-11-12 16:46:25+00:00,totalnoncurrentassets,intangibleassets,Intangible Assets,+,debit,usd,0.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2013.0,Q3,,2013-09-30,2013-11-12 16:46:25+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,94000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2013.0,Q3,,2013-09-30,2013-11-12 16:46:25+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,94000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2013.0,Q3,,2013-09-30,2013-11-12 16:46:25+00:00,,totalassets,Total Assets,=,debit,usd,88060000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2013.0,Q3,,2013-09-30,2013-11-12 16:46:25+00:00,totalcurrentliabilities,shorttermdebt,Short-Term Debt,+,credit,usd,0.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2013.0,Q3,,2013-09-30,2013-11-12 16:46:25+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,10275000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2013.0,Q3,,2013-09-30,2013-11-12 16:46:25+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,2892000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2013.0,Q3,,2013-09-30,2013-11-12 16:46:25+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,13167000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2013.0,Q3,,2013-09-30,2013-11-12 16:46:25+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,1050000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2013.0,Q3,,2013-09-30,2013-11-12 16:46:25+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,1050000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2013.0,Q3,,2013-09-30,2013-11-12 16:46:25+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,14217000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2013.0,Q3,,2013-09-30,2013-11-12 16:46:25+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2013.0,Q3,,2013-09-30,2013-11-12 16:46:25+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,225169000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2013.0,Q3,,2013-09-30,2013-11-12 16:46:25+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-151326000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2013.0,Q3,,2013-09-30,2013-11-12 16:46:25+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,73843000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2013.0,Q3,,2013-09-30,2013-11-12 16:46:25+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,73843000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2013.0,Q3,,2013-09-30,2013-11-12 16:46:25+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,73843000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2013.0,Q3,,2013-09-30,2013-11-12 16:46:25+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,88060000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2014.0,Q1,,2014-03-31,2014-05-12 17:29:09+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,20635000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2014.0,Q1,,2014-03-31,2014-05-12 17:29:09+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,50003000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2014.0,Q1,,2014-03-31,2014-05-12 17:29:09+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,5578000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2014.0,Q1,,2014-03-31,2014-05-12 17:29:09+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,76216000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2014.0,Q1,,2014-03-31,2014-05-12 17:29:09+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,589000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2014.0,Q1,,2014-03-31,2014-05-12 17:29:09+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,94000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2014.0,Q1,,2014-03-31,2014-05-12 17:29:09+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,94000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2014.0,Q1,,2014-03-31,2014-05-12 17:29:09+00:00,,totalassets,Total Assets,=,debit,usd,76899000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2014.0,Q1,,2014-03-31,2014-05-12 17:29:09+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,9931000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2014.0,Q1,,2014-03-31,2014-05-12 17:29:09+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,2663000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2014.0,Q1,,2014-03-31,2014-05-12 17:29:09+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,12594000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2014.0,Q1,,2014-03-31,2014-05-12 17:29:09+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,1311000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2014.0,Q1,,2014-03-31,2014-05-12 17:29:09+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,1311000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2014.0,Q1,,2014-03-31,2014-05-12 17:29:09+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,13905000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2014.0,Q1,,2014-03-31,2014-05-12 17:29:09+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2014.0,Q1,,2014-03-31,2014-05-12 17:29:09+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,250396000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2014.0,Q1,,2014-03-31,2014-05-12 17:29:09+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-187402000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2014.0,Q1,,2014-03-31,2014-05-12 17:29:09+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,62994000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2014.0,Q1,,2014-03-31,2014-05-12 17:29:09+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,62994000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2014.0,Q1,,2014-03-31,2014-05-12 17:29:09+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,62994000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2014.0,Q1,,2014-03-31,2014-05-12 17:29:09+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,76899000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2014.0,Q2,,2014-06-30,2014-08-11 17:08:20+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,1200000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2014.0,Q2,,2014-06-30,2014-08-11 17:08:20+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,49999000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2014.0,Q2,,2014-06-30,2014-08-11 17:08:20+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,4798000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2014.0,Q2,,2014-06-30,2014-08-11 17:08:20+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,55997000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2014.0,Q2,,2014-06-30,2014-08-11 17:08:20+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,589000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2014.0,Q2,,2014-06-30,2014-08-11 17:08:20+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,163000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2014.0,Q2,,2014-06-30,2014-08-11 17:08:20+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,163000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2014.0,Q2,,2014-06-30,2014-08-11 17:08:20+00:00,,totalassets,Total Assets,=,debit,usd,56749000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2014.0,Q2,,2014-06-30,2014-08-11 17:08:20+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,12223000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2014.0,Q2,,2014-06-30,2014-08-11 17:08:20+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,5713000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2014.0,Q2,,2014-06-30,2014-08-11 17:08:20+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,17936000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2014.0,Q2,,2014-06-30,2014-08-11 17:08:20+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,555000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2014.0,Q2,,2014-06-30,2014-08-11 17:08:20+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,555000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2014.0,Q2,,2014-06-30,2014-08-11 17:08:20+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,18491000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2014.0,Q2,,2014-06-30,2014-08-11 17:08:20+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2014.0,Q2,,2014-06-30,2014-08-11 17:08:20+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,251580000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2014.0,Q2,,2014-06-30,2014-08-11 17:08:20+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-213322000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2014.0,Q2,,2014-06-30,2014-08-11 17:08:20+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,38258000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2014.0,Q2,,2014-06-30,2014-08-11 17:08:20+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,38258000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2014.0,Q2,,2014-06-30,2014-08-11 17:08:20+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,38258000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2014.0,Q2,,2014-06-30,2014-08-11 17:08:20+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,56749000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2014.0,Q3,,2014-09-30,2014-11-10 16:01:58+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,12769000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2014.0,Q3,,2014-09-30,2014-11-10 16:01:58+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,19999000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2014.0,Q3,,2014-09-30,2014-11-10 16:01:58+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,4106000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2014.0,Q3,,2014-09-30,2014-11-10 16:01:58+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,36874000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2014.0,Q3,,2014-09-30,2014-11-10 16:01:58+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,607000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2014.0,Q3,,2014-09-30,2014-11-10 16:01:58+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,163000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2014.0,Q3,,2014-09-30,2014-11-10 16:01:58+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,163000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2014.0,Q3,,2014-09-30,2014-11-10 16:01:58+00:00,,totalassets,Total Assets,=,debit,usd,37644000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2014.0,Q3,,2014-09-30,2014-11-10 16:01:58+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,15246000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2014.0,Q3,,2014-09-30,2014-11-10 16:01:58+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,3355000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2014.0,Q3,,2014-09-30,2014-11-10 16:01:58+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,18601000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2014.0,Q3,,2014-09-30,2014-11-10 16:01:58+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,130000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2014.0,Q3,,2014-09-30,2014-11-10 16:01:58+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,130000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2014.0,Q3,,2014-09-30,2014-11-10 16:01:58+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,18731000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2014.0,Q3,,2014-09-30,2014-11-10 16:01:58+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,255243000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2014.0,Q3,,2014-09-30,2014-11-10 16:01:58+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-236330000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2014.0,Q3,,2014-09-30,2014-11-10 16:01:58+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,18913000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2014.0,Q3,,2014-09-30,2014-11-10 16:01:58+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,18913000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2014.0,Q3,,2014-09-30,2014-11-10 16:01:58+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,18913000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2014.0,Q3,,2014-09-30,2014-11-10 16:01:58+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,37644000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2015.0,Q1,,2015-03-31,2015-05-11 16:06:30+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,78718000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2015.0,Q1,,2015-03-31,2015-05-11 16:06:30+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,99910000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2015.0,Q1,,2015-03-31,2015-05-11 16:06:30+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,3649000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2015.0,Q1,,2015-03-31,2015-05-11 16:06:30+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,182277000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2015.0,Q1,,2015-03-31,2015-05-11 16:06:30+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,617000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2015.0,Q1,,2015-03-31,2015-05-11 16:06:30+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,219000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2015.0,Q1,,2015-03-31,2015-05-11 16:06:30+00:00,totalnoncurrentassets,othernoncurrentnonoperatingassets,Other Noncurrent Nonoperating Assets,+,debit,usd,11719000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2015.0,Q1,,2015-03-31,2015-05-11 16:06:30+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,11938000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2015.0,Q1,,2015-03-31,2015-05-11 16:06:30+00:00,,totalassets,Total Assets,=,debit,usd,194832000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2015.0,Q1,,2015-03-31,2015-05-11 16:06:30+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,11170000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2015.0,Q1,,2015-03-31,2015-05-11 16:06:30+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,1710000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2015.0,Q1,,2015-03-31,2015-05-11 16:06:30+00:00,totalcurrentliabilities,othercurrentnonoperatingliabilities,Other Current Nonoperating Liabilities,+,credit,usd,6250000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2015.0,Q1,,2015-03-31,2015-05-11 16:06:30+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,19130000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2015.0,Q1,,2015-03-31,2015-05-11 16:06:30+00:00,totalnoncurrentliabilities,longtermdebt,Long-Term Debt,+,credit,usd,200000000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2015.0,Q1,,2015-03-31,2015-05-11 16:06:30+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,440000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2015.0,Q1,,2015-03-31,2015-05-11 16:06:30+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,200440000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2015.0,Q1,,2015-03-31,2015-05-11 16:06:30+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,219570000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2015.0,Q1,,2015-03-31,2015-05-11 16:06:30+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2015.0,Q1,,2015-03-31,2015-05-11 16:06:30+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2015.0,Q1,,2015-03-31,2015-05-11 16:06:30+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,269536000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2015.0,Q1,,2015-03-31,2015-05-11 16:06:30+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-294274000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2015.0,Q1,,2015-03-31,2015-05-11 16:06:30+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,-24738000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2015.0,Q1,,2015-03-31,2015-05-11 16:06:30+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,-24738000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2015.0,Q1,,2015-03-31,2015-05-11 16:06:30+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,-24738000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2015.0,Q1,,2015-03-31,2015-05-11 16:06:30+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,194832000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2015.0,Q2,,2015-06-30,2015-08-10 16:11:26+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,61695000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2015.0,Q2,,2015-06-30,2015-08-10 16:11:26+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,99984000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2015.0,Q2,,2015-06-30,2015-08-10 16:11:26+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,2287000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2015.0,Q2,,2015-06-30,2015-08-10 16:11:26+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,163966000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2015.0,Q2,,2015-06-30,2015-08-10 16:11:26+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,584000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2015.0,Q2,,2015-06-30,2015-08-10 16:11:26+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,219000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2015.0,Q2,,2015-06-30,2015-08-10 16:11:26+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,219000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2015.0,Q2,,2015-06-30,2015-08-10 16:11:26+00:00,,totalassets,Total Assets,=,debit,usd,164769000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2015.0,Q2,,2015-06-30,2015-08-10 16:11:26+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,10606000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2015.0,Q2,,2015-06-30,2015-08-10 16:11:26+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,3934000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2015.0,Q2,,2015-06-30,2015-08-10 16:11:26+00:00,totalcurrentliabilities,othercurrentnonoperatingliabilities,Other Current Nonoperating Liabilities,+,credit,usd,2222000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2015.0,Q2,,2015-06-30,2015-08-10 16:11:26+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,16762000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2015.0,Q2,,2015-06-30,2015-08-10 16:11:26+00:00,totalnoncurrentliabilities,longtermdebt,Long-Term Debt,+,credit,usd,167967000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2015.0,Q2,,2015-06-30,2015-08-10 16:11:26+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,1981000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2015.0,Q2,,2015-06-30,2015-08-10 16:11:26+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,169948000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2015.0,Q2,,2015-06-30,2015-08-10 16:11:26+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,186710000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2015.0,Q2,,2015-06-30,2015-08-10 16:11:26+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2015.0,Q2,,2015-06-30,2015-08-10 16:11:26+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2015.0,Q2,,2015-06-30,2015-08-10 16:11:26+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,306001000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2015.0,Q2,,2015-06-30,2015-08-10 16:11:26+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-327942000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2015.0,Q2,,2015-06-30,2015-08-10 16:11:26+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,-21941000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2015.0,Q2,,2015-06-30,2015-08-10 16:11:26+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,-21941000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2015.0,Q2,,2015-06-30,2015-08-10 16:11:26+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,-21941000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2015.0,Q2,,2015-06-30,2015-08-10 16:11:26+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,164769000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2015.0,Q3,,2015-09-30,2015-11-09 06:48:06+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,41916000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2015.0,Q3,,2015-09-30,2015-11-09 06:48:06+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,100085000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2015.0,Q3,,2015-09-30,2015-11-09 06:48:06+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,1147000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2015.0,Q3,,2015-09-30,2015-11-09 06:48:06+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,143148000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2015.0,Q3,,2015-09-30,2015-11-09 06:48:06+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,590000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2015.0,Q3,,2015-09-30,2015-11-09 06:48:06+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,219000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2015.0,Q3,,2015-09-30,2015-11-09 06:48:06+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,219000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2015.0,Q3,,2015-09-30,2015-11-09 06:48:06+00:00,,totalassets,Total Assets,=,debit,usd,143957000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2015.0,Q3,,2015-09-30,2015-11-09 06:48:06+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,11612000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2015.0,Q3,,2015-09-30,2015-11-09 06:48:06+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,3177000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2015.0,Q3,,2015-09-30,2015-11-09 06:48:06+00:00,totalcurrentliabilities,othercurrentnonoperatingliabilities,Other Current Nonoperating Liabilities,+,credit,usd,4969000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2015.0,Q3,,2015-09-30,2015-11-09 06:48:06+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,19758000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2015.0,Q3,,2015-09-30,2015-11-09 06:48:06+00:00,totalnoncurrentliabilities,longtermdebt,Long-Term Debt,+,credit,usd,150735000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2015.0,Q3,,2015-09-30,2015-11-09 06:48:06+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,533000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2015.0,Q3,,2015-09-30,2015-11-09 06:48:06+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,151268000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2015.0,Q3,,2015-09-30,2015-11-09 06:48:06+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,171026000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2015.0,Q3,,2015-09-30,2015-11-09 06:48:06+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2015.0,Q3,,2015-09-30,2015-11-09 06:48:06+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2015.0,Q3,,2015-09-30,2015-11-09 06:48:06+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,326869000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2015.0,Q3,,2015-09-30,2015-11-09 06:48:06+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-353938000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2015.0,Q3,,2015-09-30,2015-11-09 06:48:06+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,-27069000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2015.0,Q3,,2015-09-30,2015-11-09 06:48:06+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,-27069000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2015.0,Q3,,2015-09-30,2015-11-09 06:48:06+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,-27069000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2015.0,Q3,,2015-09-30,2015-11-09 06:48:06+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,143957000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2016.0,Q1,,2016-03-31,2016-05-10 16:10:34+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,84155000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2016.0,Q1,,2016-03-31,2016-05-10 16:10:34+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,0.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2016.0,Q1,,2016-03-31,2016-05-10 16:10:34+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,3361000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2016.0,Q1,,2016-03-31,2016-05-10 16:10:34+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,87516000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2016.0,Q1,,2016-03-31,2016-05-10 16:10:34+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,534000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2016.0,Q1,,2016-03-31,2016-05-10 16:10:34+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,343000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2016.0,Q1,,2016-03-31,2016-05-10 16:10:34+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,343000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2016.0,Q1,,2016-03-31,2016-05-10 16:10:34+00:00,,totalassets,Total Assets,=,debit,usd,88393000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2016.0,Q1,,2016-03-31,2016-05-10 16:10:34+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,13561000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2016.0,Q1,,2016-03-31,2016-05-10 16:10:34+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,3229000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2016.0,Q1,,2016-03-31,2016-05-10 16:10:34+00:00,totalcurrentliabilities,othercurrentnonoperatingliabilities,Other Current Nonoperating Liabilities,+,credit,usd,2474000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2016.0,Q1,,2016-03-31,2016-05-10 16:10:34+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,19264000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2016.0,Q1,,2016-03-31,2016-05-10 16:10:34+00:00,totalnoncurrentliabilities,longtermdebt,Long-Term Debt,+,credit,usd,75565000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2016.0,Q1,,2016-03-31,2016-05-10 16:10:34+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,62000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2016.0,Q1,,2016-03-31,2016-05-10 16:10:34+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,75627000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2016.0,Q1,,2016-03-31,2016-05-10 16:10:34+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,94891000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2016.0,Q1,,2016-03-31,2016-05-10 16:10:34+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2016.0,Q1,,2016-03-31,2016-05-10 16:10:34+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2016.0,Q1,,2016-03-31,2016-05-10 16:10:34+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,437828000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2016.0,Q1,,2016-03-31,2016-05-10 16:10:34+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-444326000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2016.0,Q1,,2016-03-31,2016-05-10 16:10:34+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,-6498000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2016.0,Q1,,2016-03-31,2016-05-10 16:10:34+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,-6498000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2016.0,Q1,,2016-03-31,2016-05-10 16:10:34+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,-6498000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2016.0,Q1,,2016-03-31,2016-05-10 16:10:34+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,88393000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2016.0,Q2,,2016-06-30,2016-08-08 17:13:10+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,141219000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2016.0,Q2,,2016-06-30,2016-08-08 17:13:10+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,0.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2016.0,Q2,,2016-06-30,2016-08-08 17:13:10+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,4266000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2016.0,Q2,,2016-06-30,2016-08-08 17:13:10+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,145485000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2016.0,Q2,,2016-06-30,2016-08-08 17:13:10+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,724000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2016.0,Q2,,2016-06-30,2016-08-08 17:13:10+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,343000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2016.0,Q2,,2016-06-30,2016-08-08 17:13:10+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,343000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2016.0,Q2,,2016-06-30,2016-08-08 17:13:10+00:00,,totalassets,Total Assets,=,debit,usd,146552000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2016.0,Q2,,2016-06-30,2016-08-08 17:13:10+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,19028000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2016.0,Q2,,2016-06-30,2016-08-08 17:13:10+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,3109000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2016.0,Q2,,2016-06-30,2016-08-08 17:13:10+00:00,totalcurrentliabilities,othercurrentnonoperatingliabilities,Other Current Nonoperating Liabilities,+,credit,usd,990000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2016.0,Q2,,2016-06-30,2016-08-08 17:13:10+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,23127000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2016.0,Q2,,2016-06-30,2016-08-08 17:13:10+00:00,totalnoncurrentliabilities,longtermdebt,Long-Term Debt,+,credit,usd,75818000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2016.0,Q2,,2016-06-30,2016-08-08 17:13:10+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,85000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2016.0,Q2,,2016-06-30,2016-08-08 17:13:10+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,75903000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2016.0,Q2,,2016-06-30,2016-08-08 17:13:10+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,99030000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2016.0,Q2,,2016-06-30,2016-08-08 17:13:10+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2016.0,Q2,,2016-06-30,2016-08-08 17:13:10+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2016.0,Q2,,2016-06-30,2016-08-08 17:13:10+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,530404000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2016.0,Q2,,2016-06-30,2016-08-08 17:13:10+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-482882000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2016.0,Q2,,2016-06-30,2016-08-08 17:13:10+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,47522000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2016.0,Q2,,2016-06-30,2016-08-08 17:13:10+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,47522000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2016.0,Q2,,2016-06-30,2016-08-08 17:13:10+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,47522000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2016.0,Q2,,2016-06-30,2016-08-08 17:13:10+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,146552000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2016.0,Q3,,2016-09-30,2016-11-09 16:32:24+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,109090000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2016.0,Q3,,2016-09-30,2016-11-09 16:32:24+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,0.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2016.0,Q3,,2016-09-30,2016-11-09 16:32:24+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,1744000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2016.0,Q3,,2016-09-30,2016-11-09 16:32:24+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,110834000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2016.0,Q3,,2016-09-30,2016-11-09 16:32:24+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,635000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2016.0,Q3,,2016-09-30,2016-11-09 16:32:24+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,343000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2016.0,Q3,,2016-09-30,2016-11-09 16:32:24+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,343000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2016.0,Q3,,2016-09-30,2016-11-09 16:32:24+00:00,,totalassets,Total Assets,=,debit,usd,111812000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2016.0,Q3,,2016-09-30,2016-11-09 16:32:24+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,15801000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2016.0,Q3,,2016-09-30,2016-11-09 16:32:24+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,5242000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2016.0,Q3,,2016-09-30,2016-11-09 16:32:24+00:00,totalcurrentliabilities,othercurrentnonoperatingliabilities,Other Current Nonoperating Liabilities,+,credit,usd,2474000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2016.0,Q3,,2016-09-30,2016-11-09 16:32:24+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,23517000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2016.0,Q3,,2016-09-30,2016-11-09 16:32:24+00:00,totalnoncurrentliabilities,longtermdebt,Long-Term Debt,+,credit,usd,76070000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2016.0,Q3,,2016-09-30,2016-11-09 16:32:24+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,171000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2016.0,Q3,,2016-09-30,2016-11-09 16:32:24+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,76241000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2016.0,Q3,,2016-09-30,2016-11-09 16:32:24+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,99758000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2016.0,Q3,,2016-09-30,2016-11-09 16:32:24+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2016.0,Q3,,2016-09-30,2016-11-09 16:32:24+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2016.0,Q3,,2016-09-30,2016-11-09 16:32:24+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,535179000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2016.0,Q3,,2016-09-30,2016-11-09 16:32:24+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-523125000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2016.0,Q3,,2016-09-30,2016-11-09 16:32:24+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,12054000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2016.0,Q3,,2016-09-30,2016-11-09 16:32:24+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,12054000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2016.0,Q3,,2016-09-30,2016-11-09 16:32:24+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,12054000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2016.0,Q3,,2016-09-30,2016-11-09 16:32:24+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,111812000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2017.0,Q1,,2017-03-31,2017-05-10 16:51:59+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,139300000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2017.0,Q1,,2017-03-31,2017-05-10 16:51:59+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,6319000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2017.0,Q1,,2017-03-31,2017-05-10 16:51:59+00:00,totalcurrentassets,netinventory,"Inventories, net",+,debit,usd,9647000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2017.0,Q1,,2017-03-31,2017-05-10 16:51:59+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,8038000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2017.0,Q1,,2017-03-31,2017-05-10 16:51:59+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,163266000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2017.0,Q1,,2017-03-31,2017-05-10 16:51:59+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,568000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2017.0,Q1,,2017-03-31,2017-05-10 16:51:59+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,408000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2017.0,Q1,,2017-03-31,2017-05-10 16:51:59+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,408000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2017.0,Q1,,2017-03-31,2017-05-10 16:51:59+00:00,,totalassets,Total Assets,=,debit,usd,164242000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2017.0,Q1,,2017-03-31,2017-05-10 16:51:59+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,28445000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2017.0,Q1,,2017-03-31,2017-05-10 16:51:59+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,10203000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2017.0,Q1,,2017-03-31,2017-05-10 16:51:59+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,4260000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2017.0,Q1,,2017-03-31,2017-05-10 16:51:59+00:00,totalcurrentliabilities,othercurrentnonoperatingliabilities,Other Current Nonoperating Liabilities,+,credit,usd,581000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2017.0,Q1,,2017-03-31,2017-05-10 16:51:59+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,43489000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2017.0,Q1,,2017-03-31,2017-05-10 16:51:59+00:00,totalnoncurrentliabilities,longtermdebt,Long-Term Debt,+,credit,usd,16771000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2017.0,Q1,,2017-03-31,2017-05-10 16:51:59+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,94000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2017.0,Q1,,2017-03-31,2017-05-10 16:51:59+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,16865000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2017.0,Q1,,2017-03-31,2017-05-10 16:51:59+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,60354000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2017.0,Q1,,2017-03-31,2017-05-10 16:51:59+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2017.0,Q1,,2017-03-31,2017-05-10 16:51:59+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2017.0,Q1,,2017-03-31,2017-05-10 16:51:59+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,751484000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2017.0,Q1,,2017-03-31,2017-05-10 16:51:59+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-647596000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2017.0,Q1,,2017-03-31,2017-05-10 16:51:59+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,103888000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2017.0,Q1,,2017-03-31,2017-05-10 16:51:59+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,103888000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2017.0,Q1,,2017-03-31,2017-05-10 16:51:59+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,103888000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2017.0,Q1,,2017-03-31,2017-05-10 16:51:59+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,164242000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2017.0,Q2,,2017-06-30,2017-08-09 16:56:59+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,81960000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2017.0,Q2,,2017-06-30,2017-08-09 16:56:59+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,1782000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2017.0,Q2,,2017-06-30,2017-08-09 16:56:59+00:00,totalcurrentassets,netinventory,"Inventories, net",+,debit,usd,11853000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2017.0,Q2,,2017-06-30,2017-08-09 16:56:59+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,8368000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2017.0,Q2,,2017-06-30,2017-08-09 16:56:59+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,103963000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2017.0,Q2,,2017-06-30,2017-08-09 16:56:59+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,529000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2017.0,Q2,,2017-06-30,2017-08-09 16:56:59+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,407000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2017.0,Q2,,2017-06-30,2017-08-09 16:56:59+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,407000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2017.0,Q2,,2017-06-30,2017-08-09 16:56:59+00:00,,totalassets,Total Assets,=,debit,usd,104899000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2017.0,Q2,,2017-06-30,2017-08-09 16:56:59+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,30460000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2017.0,Q2,,2017-06-30,2017-08-09 16:56:59+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,12390000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2017.0,Q2,,2017-06-30,2017-08-09 16:56:59+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,1498000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2017.0,Q2,,2017-06-30,2017-08-09 16:56:59+00:00,totalcurrentliabilities,othercurrentnonoperatingliabilities,Other Current Nonoperating Liabilities,+,credit,usd,233000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2017.0,Q2,,2017-06-30,2017-08-09 16:56:59+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,44581000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2017.0,Q2,,2017-06-30,2017-08-09 16:56:59+00:00,totalnoncurrentliabilities,longtermdebt,Long-Term Debt,+,credit,usd,16948000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2017.0,Q2,,2017-06-30,2017-08-09 16:56:59+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,55000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2017.0,Q2,,2017-06-30,2017-08-09 16:56:59+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,17003000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2017.0,Q2,,2017-06-30,2017-08-09 16:56:59+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,61584000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2017.0,Q2,,2017-06-30,2017-08-09 16:56:59+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2017.0,Q2,,2017-06-30,2017-08-09 16:56:59+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2017.0,Q2,,2017-06-30,2017-08-09 16:56:59+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,764800000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2017.0,Q2,,2017-06-30,2017-08-09 16:56:59+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-721485000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2017.0,Q2,,2017-06-30,2017-08-09 16:56:59+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,43315000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2017.0,Q2,,2017-06-30,2017-08-09 16:56:59+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,43315000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2017.0,Q2,,2017-06-30,2017-08-09 16:56:59+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,43315000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2017.0,Q2,,2017-06-30,2017-08-09 16:56:59+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,104899000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2017.0,Q3,,2017-09-30,2017-11-09 17:07:57+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,117800000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2017.0,Q3,,2017-09-30,2017-11-09 17:07:57+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,5036000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2017.0,Q3,,2017-09-30,2017-11-09 17:07:57+00:00,totalcurrentassets,netinventory,"Inventories, net",+,debit,usd,13045000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2017.0,Q3,,2017-09-30,2017-11-09 17:07:57+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,8560000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2017.0,Q3,,2017-09-30,2017-11-09 17:07:57+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,144428000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2017.0,Q3,,2017-09-30,2017-11-09 17:07:57+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,1045000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2017.0,Q3,,2017-09-30,2017-11-09 17:07:57+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,318000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2017.0,Q3,,2017-09-30,2017-11-09 17:07:57+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,318000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2017.0,Q3,,2017-09-30,2017-11-09 17:07:57+00:00,,totalassets,Total Assets,=,debit,usd,145791000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2017.0,Q3,,2017-09-30,2017-11-09 17:07:57+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,17182000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2017.0,Q3,,2017-09-30,2017-11-09 17:07:57+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,14208000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2017.0,Q3,,2017-09-30,2017-11-09 17:07:57+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,1927000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2017.0,Q3,,2017-09-30,2017-11-09 17:07:57+00:00,totalcurrentliabilities,othercurrentnonoperatingliabilities,Other Current Nonoperating Liabilities,+,credit,usd,581000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2017.0,Q3,,2017-09-30,2017-11-09 17:07:57+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,33898000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2017.0,Q3,,2017-09-30,2017-11-09 17:07:57+00:00,totalnoncurrentliabilities,longtermdebt,Long-Term Debt,+,credit,usd,113102000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2017.0,Q3,,2017-09-30,2017-11-09 17:07:57+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,460000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2017.0,Q3,,2017-09-30,2017-11-09 17:07:57+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,113562000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2017.0,Q3,,2017-09-30,2017-11-09 17:07:57+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,147460000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2017.0,Q3,,2017-09-30,2017-11-09 17:07:57+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2017.0,Q3,,2017-09-30,2017-11-09 17:07:57+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2017.0,Q3,,2017-09-30,2017-11-09 17:07:57+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,768687000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2017.0,Q3,,2017-09-30,2017-11-09 17:07:57+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-770356000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2017.0,Q3,,2017-09-30,2017-11-09 17:07:57+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,-1669000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2017.0,Q3,,2017-09-30,2017-11-09 17:07:57+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,-1669000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2017.0,Q3,,2017-09-30,2017-11-09 17:07:57+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,-1669000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2017.0,Q3,,2017-09-30,2017-11-09 17:07:57+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,145791000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2018.0,Q1,,2018-03-31,2018-05-10 16:32:40+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,98658000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2018.0,Q1,,2018-03-31,2018-05-10 16:32:40+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,7414000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2018.0,Q1,,2018-03-31,2018-05-10 16:32:40+00:00,totalcurrentassets,netinventory,"Inventories, net",+,debit,usd,16175000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2018.0,Q1,,2018-03-31,2018-05-10 16:32:40+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,8924000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2018.0,Q1,,2018-03-31,2018-05-10 16:32:40+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,131171000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2018.0,Q1,,2018-03-31,2018-05-10 16:32:40+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,1163000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2018.0,Q1,,2018-03-31,2018-05-10 16:32:40+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,312000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2018.0,Q1,,2018-03-31,2018-05-10 16:32:40+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,312000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2018.0,Q1,,2018-03-31,2018-05-10 16:32:40+00:00,,totalassets,Total Assets,=,debit,usd,132646000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2018.0,Q1,,2018-03-31,2018-05-10 16:32:40+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,22976000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2018.0,Q1,,2018-03-31,2018-05-10 16:32:40+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,13933000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2018.0,Q1,,2018-03-31,2018-05-10 16:32:40+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,5000000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2018.0,Q1,,2018-03-31,2018-05-10 16:32:40+00:00,totalcurrentliabilities,othercurrentnonoperatingliabilities,Other Current Nonoperating Liabilities,+,credit,usd,581000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2018.0,Q1,,2018-03-31,2018-05-10 16:32:40+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,42490000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2018.0,Q1,,2018-03-31,2018-05-10 16:32:40+00:00,totalnoncurrentliabilities,longtermdebt,Long-Term Debt,+,credit,usd,116445000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2018.0,Q1,,2018-03-31,2018-05-10 16:32:40+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,12344000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2018.0,Q1,,2018-03-31,2018-05-10 16:32:40+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,128789000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2018.0,Q1,,2018-03-31,2018-05-10 16:32:40+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,171279000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2018.0,Q1,,2018-03-31,2018-05-10 16:32:40+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2018.0,Q1,,2018-03-31,2018-05-10 16:32:40+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2018.0,Q1,,2018-03-31,2018-05-10 16:32:40+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,804801000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2018.0,Q1,,2018-03-31,2018-05-10 16:32:40+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-843434000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2018.0,Q1,,2018-03-31,2018-05-10 16:32:40+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,-38633000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2018.0,Q1,,2018-03-31,2018-05-10 16:32:40+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,-38633000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2018.0,Q1,,2018-03-31,2018-05-10 16:32:40+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,-38633000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2018.0,Q1,,2018-03-31,2018-05-10 16:32:40+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,132646000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2018.0,Q2,,2018-06-30,2018-08-08 13:12:47+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,61200000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2018.0,Q2,,2018-06-30,2018-08-08 13:12:47+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,8511000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2018.0,Q2,,2018-06-30,2018-08-08 13:12:47+00:00,totalcurrentassets,netinventory,"Inventories, net",+,debit,usd,17609000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2018.0,Q2,,2018-06-30,2018-08-08 13:12:47+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,7772000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2018.0,Q2,,2018-06-30,2018-08-08 13:12:47+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,95125000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2018.0,Q2,,2018-06-30,2018-08-08 13:12:47+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,1168000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2018.0,Q2,,2018-06-30,2018-08-08 13:12:47+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,312000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2018.0,Q2,,2018-06-30,2018-08-08 13:12:47+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,312000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2018.0,Q2,,2018-06-30,2018-08-08 13:12:47+00:00,,totalassets,Total Assets,=,debit,usd,96605000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2018.0,Q2,,2018-06-30,2018-08-08 13:12:47+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,12912000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2018.0,Q2,,2018-06-30,2018-08-08 13:12:47+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,15453000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2018.0,Q2,,2018-06-30,2018-08-08 13:12:47+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,5000000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2018.0,Q2,,2018-06-30,2018-08-08 13:12:47+00:00,totalcurrentliabilities,othercurrentnonoperatingliabilities,Other Current Nonoperating Liabilities,+,credit,usd,233000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2018.0,Q2,,2018-06-30,2018-08-08 13:12:47+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,33598000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2018.0,Q2,,2018-06-30,2018-08-08 13:12:47+00:00,totalnoncurrentliabilities,longtermdebt,Long-Term Debt,+,credit,usd,117984000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2018.0,Q2,,2018-06-30,2018-08-08 13:12:47+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,9713000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2018.0,Q2,,2018-06-30,2018-08-08 13:12:47+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,127697000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2018.0,Q2,,2018-06-30,2018-08-08 13:12:47+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,161295000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2018.0,Q2,,2018-06-30,2018-08-08 13:12:47+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2018.0,Q2,,2018-06-30,2018-08-08 13:12:47+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2018.0,Q2,,2018-06-30,2018-08-08 13:12:47+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,808435000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2018.0,Q2,,2018-06-30,2018-08-08 13:12:47+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-873125000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2018.0,Q2,,2018-06-30,2018-08-08 13:12:47+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,-64690000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2018.0,Q2,,2018-06-30,2018-08-08 13:12:47+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,-64690000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2018.0,Q2,,2018-06-30,2018-08-08 13:12:47+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,-64690000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2018.0,Q2,,2018-06-30,2018-08-08 13:12:47+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,96605000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2018.0,Q3,,2018-09-30,2018-11-09 09:06:13+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,45647000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2018.0,Q3,,2018-09-30,2018-11-09 09:06:13+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,9222000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2018.0,Q3,,2018-09-30,2018-11-09 09:06:13+00:00,totalcurrentassets,netinventory,"Inventories, net",+,debit,usd,21530000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2018.0,Q3,,2018-09-30,2018-11-09 09:06:13+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,5259000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2018.0,Q3,,2018-09-30,2018-11-09 09:06:13+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,81658000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2018.0,Q3,,2018-09-30,2018-11-09 09:06:13+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,1069000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2018.0,Q3,,2018-09-30,2018-11-09 09:06:13+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,312000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2018.0,Q3,,2018-09-30,2018-11-09 09:06:13+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,312000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2018.0,Q3,,2018-09-30,2018-11-09 09:06:13+00:00,,totalassets,Total Assets,=,debit,usd,83039000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2018.0,Q3,,2018-09-30,2018-11-09 09:06:13+00:00,totalcurrentliabilities,shorttermdebt,Short-Term Debt,+,credit,usd,119573000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2018.0,Q3,,2018-09-30,2018-11-09 09:06:13+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,11549000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2018.0,Q3,,2018-09-30,2018-11-09 09:06:13+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,21225000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2018.0,Q3,,2018-09-30,2018-11-09 09:06:13+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,5000000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2018.0,Q3,,2018-09-30,2018-11-09 09:06:13+00:00,totalcurrentliabilities,othercurrentnonoperatingliabilities,Other Current Nonoperating Liabilities,+,credit,usd,581000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2018.0,Q3,,2018-09-30,2018-11-09 09:06:13+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,157928000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2018.0,Q3,,2018-09-30,2018-11-09 09:06:13+00:00,totalnoncurrentliabilities,longtermdebt,Long-Term Debt,+,credit,usd,0.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2018.0,Q3,,2018-09-30,2018-11-09 09:06:13+00:00,totalnoncurrentliabilities,noncurrentdeferredrevenue,Noncurrent Deferred Revenue,+,credit,usd,11236000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2018.0,Q3,,2018-09-30,2018-11-09 09:06:13+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,10119000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2018.0,Q3,,2018-09-30,2018-11-09 09:06:13+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,21355000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2018.0,Q3,,2018-09-30,2018-11-09 09:06:13+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,179283000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2018.0,Q3,,2018-09-30,2018-11-09 09:06:13+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2018.0,Q3,,2018-09-30,2018-11-09 09:06:13+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2018.0,Q3,,2018-09-30,2018-11-09 09:06:13+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,811424000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2018.0,Q3,,2018-09-30,2018-11-09 09:06:13+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-907668000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2018.0,Q3,,2018-09-30,2018-11-09 09:06:13+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,-96244000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2018.0,Q3,,2018-09-30,2018-11-09 09:06:13+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,-96244000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2018.0,Q3,,2018-09-30,2018-11-09 09:06:13+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,-96244000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2018.0,Q3,,2018-09-30,2018-11-09 09:06:13+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,83039000.0
